The Federal Trade Commission will revisit web sites whose operators have been warned that claims that their products can prevent, treat or cure the influenza (A) H1N1 virus, commonly known as swine flu, that they must be backed by scientific proof, or face law enforcement action.
"Scam artists follow the headlines, trying to make a fast buck with products that play off the news and prey on concerned people," said Eileen Harrington, acting director of the FTC's Bureau of Consumer Protection. She added: "we're on-line and telling e-marketers their sites must comply with the law." The FTC reminds consumers that the only products recommended for use are the prescription antiviral drugs, Tamiflu (oseltamivir) and Relenza (zanamivir).
The federal agency's staff identified 10 Web sites making suspect flu treatment, prevention or cure claims. Of these, four USA-based web sites already have complied, the FTC said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze